Status:
COMPLETED
MYometrial Lesion UltrasouNd And mRi
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Sarcoma Uterus
Eligibility:
FEMALE
Brief Summary
A monocentric prospective observational study aimed at assessing the accuracy of a diagnostic algorithm to pre-operatively identify uterine sarcomas.. Primary Aim:The primary outcome is to evaluate t...
Detailed Description
INTRODUCTION Uterine sarcomas are rare malignant tumors arising from the mesenchymal tissues of the uterus including the endometrial stroma, uterine muscle and connective tissue. They represent 1% of...
Eligibility Criteria
Inclusion
- Consecutive patients admitted to our Department for transvaginal ultrasound examination, in whom a myometrial lesion \> 3cm in size is detected.
- Informed consent form signed by the patient.
Exclusion
- Patients undergoing medical treatment for myometrial lesion;
- Patients previously treated with hormonal therapy including estroprogestin in the last six months;
- Patients previously treated by embolization
Key Trial Info
Start Date :
January 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 4 2023
Estimated Enrollment :
2353 Patients enrolled
Trial Details
Trial ID
NCT04123158
Start Date
January 17 2019
End Date
December 4 2023
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Agostino Gemelli
Rome, Italy, 00191